Search Browse Earnings

LIFECORE BIOMEDICAL, INC. \DE\ — SlamSEC

LIFECORE BIOMEDICAL, INC. \DE\

Nasdaq:LFCR

Pharmaceutical Preparations·CHASKA, MN

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CFO

Lake Ryan David

Revenue

$115.8M

-75.7% YoY

FY 2019

Adj. EBITDA

-$890,000

-0.8% margin

FY 2025

Net Income

$12.0M

10.4% margin

FY 2025

EPS (Diluted)

$0.33

FY 2025

Stock Price

$6.72

-3.6%

2026-03-11

52W Range

$4.76 – $8.98

P/E Ratio

20.4x

Market Cap

$251.8M

Cash

$8.5M

FY 2025

Total Debt

$84.3M

FY 2024

Net Debt

$75.8M

FY 2024

Enterprise Value

$327.6M

Debt / EBITDA

-85.2x

FY 2019

EV / EBITDA

-368.1x

Employees

—